Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-alcoholic Steatohepatitis NASH”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00389376
What this trial is testing

Phase I Trial of Silymarin for Chronic Liver Diseases

Who this might be right for
Hepatitis CNon-Alcoholic Fatty Liver Disease
National Center for Complementary and Integrative Health (NCCIH) 56
Not applicableUnknownNCT06413069
What this trial is testing

Effects of Almonds in Glucose-intolerant Adults (AGAMEMNON)

Who this might be right for
PreDiabetesNAFLD
Charite University, Berlin, Germany 150
Large-scale testing (Phase 3)Looking for participantsNCT06318169
What this trial is testing

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc. 1,350
Not applicableNot Yet RecruitingNCT04925362
What this trial is testing

THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)

Who this might be right for
NAFLDNASHNASH - Nonalcoholic Steatohepatitis+2 more
Assistance Publique - Hôpitaux de Paris 900
Not applicableLooking for participantsNCT07070362
What this trial is testing

Digital Early Warning System for Acute Lung Injury in Liver Surgery

Who this might be right for
Acute Lung Injury(ALI)Liver CirrhosisARDS, Human+4 more
Beijing Tsinghua Chang Gung Hospital 3,000
Testing effectiveness (Phase 2)Study completedNCT02686762
What this trial is testing

Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis

Who this might be right for
Non-alcoholic SteatohepatitisFibrosisLiver Diseases
Conatus Pharmaceuticals Inc. 318
Not applicableUnknownNCT02716870
What this trial is testing

Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors

Who this might be right for
DyslipidemiaDiabetesPrediabetes+5 more
University of Toronto 1
Early research (Phase 1)Looking for participantsNCT06704516
What this trial is testing

COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study

Who this might be right for
MenopauseMetabolic Dysfunction Associated Steatotic Liver Disease
University of Oxford 10
Not applicableLooking for participantsNCT06203548
What this trial is testing

Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter

Who this might be right for
Fatty Liver
Chinese University of Hong Kong 150
Not applicableStudy completedNCT01354626
What this trial is testing

Dietary Protein and Hepatic Fat Accumulation

Who this might be right for
Hepatic Fat AccumulationNonalcoholic Fatty Liver Disease
Wageningen University 29
Testing effectiveness (Phase 2)Study completedNCT05364684
What this trial is testing

The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLDNonalcoholic Fatty LiverNASH - Nonalcoholic Steatohepatitis
Massachusetts General Hospital 12
Not applicableStudy completedNCT05402449
What this trial is testing

To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota Modulation

Who this might be right for
Non-Alcoholic Fatty Liver Disease
GenMont Biotech Incorporation 70
Not applicableUnknownNCT04215926
What this trial is testing

NAFLD in HIV-infected Patients

Who this might be right for
HIV-infection/AidsNAFLD
Shanghai Public Health Clinical Center 400
Not applicableUnknownNCT01791452
What this trial is testing

Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver Disease: A Prospective Clinical Study

Who this might be right for
Non-alcoholic Fatty Liver DiseaseCholesterol Ester Storage Disease
Assy Nimer
Not applicableLooking for participantsNCT06803108
What this trial is testing

Pyramidal Versus Continuous Training Effects on Fatty Liver

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Cairo University 38
Testing effectiveness (Phase 2)Looking for participantsNCT06661538
What this trial is testing

Implementing Food Referrals for Equity and Sustained Health

Who this might be right for
Food Insecurity
University of California, San Diego 600
Not applicableStudy completedNCT07539584
What this trial is testing

Adiponectin in Patients With Metabolic Disorders

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)Type 2 Diabetes Mellitus (T2DM)
Moscow Regional Research and Clinical Institute (MONIKI) 130
Large-scale testing (Phase 3)Study completedNCT02535195
What this trial is testing

Effect of Ginger Supplement on Non-alcoholic Fatty Liver

Who this might be right for
Non-alcoholic Fatty Liver Disease
Dr Azita Hekmatdoost 60
Not applicableEnrolling By InvitationNCT07493967
What this trial is testing

Short and Long Term Clinical and Patient-Reported Outcomes Associated With Intragastric Balloon Placement in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLD
Methodist Health System 200
Not applicableStudy completedNCT06940375
What this trial is testing

Incidence of Liver Disease-Related Outcomes in People With HIV

Who this might be right for
MAFLDLiver FibrosisMASH+3 more
Shanghai Public Health Clinical Center 315
Next Page